Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study follows 500 seniors with heart devices to improve care decisions

NCT ID NCT05116176

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Beth Israel Deaconess Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 500 patients over age 65 who are receiving a new implantable cardioverter-defibrillator (ICD) for the first time to prevent sudden cardiac arrest. Researchers will track their health, quality of life, and experiences for 18 months, with optional follow-up up to 10 years. The goal is to better understand how patients fare after getting an ICD and to improve tools that help doctors and patients make informed decisions together.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
implantable cardioverter-defibrillator (ICD)
What this could lead to
If successful, this study could help doctors better predict which older patients will benefit most from an ICD and improve shared decision-making.
What could go wrong
This is an observational study, not a treatment trial. It will not test a new therapy, and results may not apply to all patients or change current practice directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMPLANTABLE DEFIBRILLATOR USER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IMPLANTABLE DEFIBRILLATOR USER

Contacts and locations

Locations

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.